Literature DB >> 4340219

Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man.

S S Marennikova, E M Seluhina, N N Mal'ceva, K L Cimiskjan, G R Macevic.   

Abstract

The causal agent of a case of disease in man occurring in the Democratic Republic of the Congo with a similar clinical picture to smallpox was isolated and studied. The agent was identified as monkeypox virus. A comparative study of the isolated strain (Congo-8) and of viruses isolated from similar cases of illness in Liberia (Liberia-1 and Liberia-2 strains) and Sierra Leone (V-70 1 266 strain) showed that they were identical. A number of local species of monkeys and apes were examined serologically in the Congo region to determine the probability of human infection with monkeypox virus. It was confirmed that the animals had had contact with an agent of the poxvirus group. In 2 of the 7 sera examined, antibodies of the variola-vaccinia group of poxviruses were discovered (virus-neutralizing antibodies, precipitins, and antihaemagglutinins). In a chimpanzee, antihaemagglutinins were found in a titre of 1: 1 280, and in the same animal a variola-like virus was isolated from the kidneys. In the course of the investigation, it was shown conclusively that monkeypox virus and the strains under investigation could be distinguished from o dinary variola and vaccinia viruses on the basis of their behaviour in pig embryo kidney continuous cell line culture.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4340219      PMCID: PMC2480798     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Studies on a pox disease of monkeys. II. Isolation of the etiologic agent.

Authors:  J E PRIER; R M SAUER; R G MALSBERGER; J M SILLAMAN
Journal:  Am J Vet Res       Date:  1960-05       Impact factor: 1.156

2.  Studies with poxviruses by an improved plaque technique.

Authors:  J S PORTERFIELD; A C ALLISON
Journal:  Virology       Date:  1960-02       Impact factor: 3.616

3.  The titration of vaccinial neutralizing antibody on chorio-allantoic membranes.

Authors:  E A BOULTER
Journal:  J Hyg (Lond)       Date:  1957-12

4.  An in-vitro test of the toxin-producing capacity of Corynebacterium diphtheriae.

Authors:  O OUCHTERLONY
Journal:  Lancet       Date:  1949-02-26       Impact factor: 79.321

5.  Comparative studies on the properties of variola virus strains. I. Characteristics of chorioallantoic membrane lesions and pathogenicity for chick embryos after different methods of inoculation.

Authors:  S S Marennikova; R A Shafikova
Journal:  Acta Virol       Date:  1969-11       Impact factor: 1.162

6.  Some entomological and epidemiological observations on the 1964 outbreak of Chikungunya fever in South India.

Authors:  R Reuben
Journal:  Indian J Med Res       Date:  1967-01       Impact factor: 2.375

7.  A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.

Authors:  I D Ladnyj; P Ziegler; E Kima
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

  7 in total
  36 in total

1.  Species-level identification of orthopoxviruses with an oligonucleotide microchip.

Authors:  Sergey Lapa; Maxim Mikheev; Sergei Shchelkunov; Vladimir Mikhailovich; Alexander Sobolev; Vladimir Blinov; Igor Babkin; Alexander Guskov; Elena Sokunova; Alexander Zasedatelev; Lev Sandakhchiev; Andrei Mirzabekov
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Eradication of smallpox: the critical year ahead.

Authors:  D A Henderson
Journal:  Proc R Soc Med       Date:  1973-06

3.  Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay.

Authors:  H D Hutchinson; D W Ziegler; D E Wells; J H Nakano
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease.

Authors:  Mary G Reynolds; Darin S Carroll; Victoria A Olson; Christine Hughes; Jack Galley; Anna Likos; Joel M Montgomery; Richard Suu-Ire; Mubarak O Kwasi; J Jeffrey Root; Zach Braden; Jason Abel; Cody Clemmons; Russell Regnery; Kevin Karem; Inger K Damon
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses.

Authors:  T Yoshii; R Kono
Journal:  J Hyg (Lond)       Date:  1978-10

6.  Evaluation of virological laboratory methods for smallpox diagnosis.

Authors:  J H Nakano
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

7.  Poxviruses isolated from clinically ill and asymptomatically infected monkeys and a chimpanzee.

Authors:  S S Marennikova; E M Seluhina; N N Mal'ceva; I D Ladnyj
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.

Authors:  I D Ladnyj; P Ziegler; E Kima
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Inhibition of monkeypox virus replication by RNA interference.

Authors:  Abdulnaser Alkhalil; Sarah Strand; Eric Mucker; John W Huggins; Peter B Jahrling; Sofi M Ibrahim
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099

10.  Virion polypeptides of poxviruses.

Authors:  M Arita; I Tagaya
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.